AR091520A1 - Inhibidores piranopiridona de tanquirasa - Google Patents
Inhibidores piranopiridona de tanquirasaInfo
- Publication number
- AR091520A1 AR091520A1 ARP130102188A AR091520A1 AR 091520 A1 AR091520 A1 AR 091520A1 AR P130102188 A ARP130102188 A AR P130102188A AR 091520 A1 AR091520 A1 AR 091520A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- heterocycloalkyl
- tanquirasa
- pyranopiridone
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/153—Ortho-condensed systems the condensed system containing two rings with oxygen as ring hetero atom and one ring with nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Los compuestos presentan actividad como agentes anticáncer. Reivindicación 1: Compuesto de fórmula (1) ó (2), en la que: X es, independientemente en cada aparición, N o CH; Y es S, O, CH ó NCH₃; M es S o CH; R¹ es H, alquilo C₁₋₆, cicloalquilo C₃₋₇, C₍CH₃)₂OH, CN, NO₂, CO₂CH₃, CONH₂, NH₂, o halógeno, y R² se selecciona de entre el grupo que consiste de H, alquilo C₁₋₆ opcionalmente sustituido, espiroalquilo C₅₋₁₂, alcoxi C₁₋₆, cicloalquilo C₃₋₇, heterocicloalquilo y heterocicloalquilo sustituido, en el que dicho heterocicloalquilo se sustituye opcionalmente con alquilo C₁₋₆, hidroxialquilo C₁₋₆, alcoxi C₁₋₃-alquilo C₁₋₆, oxetanilo, tetrahidrofuranilo, piranilo o SO₂R³, en el que R³ es alquilo C₁₋₆, hidroxialquilo C₁₋₆, oxetanilo, tetrahidrofuranilo, piranilo, o una sal farmacéuticamente aceptable de los mismos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261661915P | 2012-06-20 | 2012-06-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR091520A1 true AR091520A1 (es) | 2015-02-11 |
Family
ID=48628700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP130102188 AR091520A1 (es) | 2012-06-20 | 2013-06-19 | Inhibidores piranopiridona de tanquirasa |
Country Status (12)
Country | Link |
---|---|
US (1) | US20140121231A1 (es) |
EP (1) | EP2864335A1 (es) |
JP (1) | JP2015520204A (es) |
KR (1) | KR20150009599A (es) |
CN (1) | CN104284898A (es) |
AR (1) | AR091520A1 (es) |
BR (1) | BR112014031785A2 (es) |
CA (1) | CA2869239A1 (es) |
HK (1) | HK1201066A1 (es) |
MX (1) | MX2014015345A (es) |
RU (1) | RU2014152792A (es) |
WO (1) | WO2013189904A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9193689B2 (en) | 2012-03-07 | 2015-11-24 | Institute Of Cancer Research: Royal Cancer Hospital (The) | 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use |
KR20150011838A (ko) * | 2012-06-20 | 2015-02-02 | 에프. 호프만-라 로슈 아게 | 탄키라아제 억제제로서의 피롤로피라존 |
WO2014087165A1 (en) * | 2012-12-06 | 2014-06-12 | University Of Bath | Tankyrase inhibitors |
ES2666729T3 (es) | 2013-09-11 | 2018-05-07 | Institute Of Cancer Research: Royal Cancer Hospital (The) | Compuestos de isoquinolin-1-ona 3-aril-5-sustituida y su uso terapéutico |
WO2015176135A1 (en) * | 2014-05-22 | 2015-11-26 | The University Of Sydney | Omega-3 analogues |
WO2017156350A1 (en) | 2016-03-09 | 2017-09-14 | K-Gen, Inc. | Methods of cancer treatment |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003014121A1 (en) * | 2001-08-07 | 2003-02-20 | Guilford Pharmaceuticals Inc. | Compounds, derivatives, compositions, preparation and uses |
MXPA06009701A (es) * | 2004-02-26 | 2007-03-26 | Inotek Pharmaceuticals Corp | Derivados de isoquinolina y metodos de uso de los mismos. |
US20060079510A1 (en) * | 2004-09-30 | 2006-04-13 | Kristoffer Hellstrand | Use of PARP-1 inhibitors for protecting tumorcidal lymphocytes from apoptosis |
US7576080B2 (en) | 2004-12-23 | 2009-08-18 | Memory Pharmaceuticals Corporation | Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors |
KR100931411B1 (ko) | 2005-04-05 | 2009-12-10 | 에프. 호프만-라 로슈 아게 | 1h-피라졸 4-카복실아미드, 이의 제조 방법, 및 이의 11베타-하이드록시스테로이드 탈수소효소로서의 용도 |
US20080242861A1 (en) | 2007-04-02 | 2008-10-02 | Chi-Feng Yen | Synthesis of amino-protected cyclohexane-1,4-diyldimethanamine and its derivatives |
AU2009274454A1 (en) | 2008-04-21 | 2010-01-28 | Merck Sharp & Dohme Corp. | Inhibitors of janus kinases |
-
2013
- 2013-06-18 BR BR112014031785A patent/BR112014031785A2/pt not_active IP Right Cessation
- 2013-06-18 WO PCT/EP2013/062563 patent/WO2013189904A1/en active Application Filing
- 2013-06-18 MX MX2014015345A patent/MX2014015345A/es unknown
- 2013-06-18 KR KR20147035760A patent/KR20150009599A/ko not_active Application Discontinuation
- 2013-06-18 CN CN201380024545.XA patent/CN104284898A/zh active Pending
- 2013-06-18 RU RU2014152792A patent/RU2014152792A/ru unknown
- 2013-06-18 EP EP13729366.8A patent/EP2864335A1/en not_active Withdrawn
- 2013-06-18 JP JP2015517716A patent/JP2015520204A/ja active Pending
- 2013-06-18 CA CA2869239A patent/CA2869239A1/en not_active Abandoned
- 2013-06-19 AR ARP130102188 patent/AR091520A1/es unknown
- 2013-06-19 US US13/921,937 patent/US20140121231A1/en not_active Abandoned
-
2015
- 2015-02-12 HK HK15101545.1A patent/HK1201066A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2869239A1 (en) | 2013-12-27 |
WO2013189904A1 (en) | 2013-12-27 |
BR112014031785A2 (pt) | 2017-06-27 |
KR20150009599A (ko) | 2015-01-26 |
HK1201066A1 (en) | 2015-08-21 |
CN104284898A (zh) | 2015-01-14 |
EP2864335A1 (en) | 2015-04-29 |
JP2015520204A (ja) | 2015-07-16 |
MX2014015345A (es) | 2015-03-05 |
US20140121231A1 (en) | 2014-05-01 |
RU2014152792A (ru) | 2016-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2018000187A (es) | Derivados de pirazolo[1,5-a]pirazin-4-ilo | |
AR090292A1 (es) | Compuestos basados en pirazolo[1,5-a]pirimidina, composiciones que los comprenden y metodos que los utilizan | |
AR091520A1 (es) | Inhibidores piranopiridona de tanquirasa | |
AR105845A1 (es) | Compuestos de heteroarilo bicíclicos fusionados como moduladores de la función irak4 | |
AR093759A1 (es) | Dihidropiridona p1 como inhibidores del factor xia | |
AR092269A1 (es) | Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
EA201790661A3 (ru) | Ингибиторы вируса гепатита c | |
AR081058A1 (es) | Derivados de arilmetoxi isoindolina, composiciones que los comprenden y su uso en el tratamiento del cancer. | |
AR091271A1 (es) | Pirrolopirimidona y pirrolopiridona, inhibidores de tanquirasa | |
AR067757A1 (es) | Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales. | |
PE20142456A1 (es) | COMPUESTOS DE OXAZOLIDIN-2-ONA Y USOS DE LOS MISMOS COMO INHIBIDORES DE LA PI3Ks | |
AR088235A1 (es) | Derivados de pirazoloquinolina | |
AR057131A1 (es) | Derivados de purina como inmunomodulador | |
AR095885A1 (es) | Compuestos derivados de arilpirrolopiridina como inhibidores de lrrk2 | |
AR097079A1 (es) | SALES DE DERIVADOS DE 2-AMINO-1-HIDROXIETIL-8-HIDROXIQUINOLIN-2(1H)-ONA QUE TIENEN ACTIVIDAD ANTAGONISTA DE RECEPTORES MUSCARÍNICOS ASÍ COMO ACTIVIDAD AGONISTA DEL RECEPTOR b2 ADRENÉRGICO | |
AR106865A1 (es) | Piridinas sustituidas y métodos de uso | |
AR083879A1 (es) | Analogos de aminoglicosidos antibacterianos, metodos de preparacion y uso como agentes terapeuticos | |
AR089781A1 (es) | Fluorometil-5,6-dihidro-4h-[1,3]oxazinas | |
PE20142366A1 (es) | Compuestos triazolo como inhibidores de pde 10 | |
AR097866A1 (es) | Derivados de 4-azaindol | |
AR090474A1 (es) | Compuestos de tetrahidropirrolotiazina | |
CO2017000980A2 (es) | Compuestos derivados de imidazo[1,2-b]piridazin-2-carboxamida e imidazo[1,2- b]piridazin-2-ilmetanona activos como inhibidores selectivos de la fosfodiesterasa 4a (pde4a) | |
AR097543A1 (es) | COMPUESTOS BASADOS EN IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y SUS MÉTODOS DE USO | |
AR088320A1 (es) | Derivados de isoindolinona y pirrolopiridinona como inhibidores de akt | |
AR085750A1 (es) | Derivados de pirazolo-pirimidina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |